Company Overview - Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapies for advanced solid tumors and other serious diseases [4] - The company's investigational drug, certepetide, aims to enhance the targeting and penetration of anti-cancer drugs in solid tumors through a novel uptake pathway [4] - Lisata has established significant commercial and R&D partnerships based on its CendR Platform® technology [4] Financial Results Announcement - The company will report its financial results for the three months ended March 31, 2025, on May 8, 2025, after the market closes [1] - A conference call will be held at 4:30 p.m. Eastern time on the same day to discuss the financial results [1] Participation in Conference Call - Interested participants must register for the conference call via a provided link and will receive an email with dial-in details [2] - To ensure a smooth experience, participants are encouraged to join the call 15 minutes early [2] Webcast Availability - A live webcast of the conference call will be available on Lisata's website under the Investors & News section [3] - The webcast will be accessible for replay starting two hours after the call and will remain available for 12 months [3] Future Expectations - The company anticipates announcing several milestones over the next 1.5 years and believes its projected capital will support operations into the second quarter of 2026 [4]